AMN Healthcare Services Inc (AMN)
Return on equity (ROE)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | -146,979 | 53,043 | 99,228 | 143,897 | 210,679 | 279,987 | 319,258 | 382,152 | 444,050 | 478,470 | 460,048 | 403,018 | 327,388 | 220,479 | 172,523 | 128,078 | 70,665 | 88,839 | 86,287 | 92,831 |
Total stockholders’ equity | US$ in thousands | 706,620 | 890,665 | 876,859 | 854,191 | 831,256 | 817,169 | 766,297 | 955,774 | 1,043,630 | 1,132,630 | 1,039,340 | 1,080,930 | 1,162,030 | 1,042,480 | 966,382 | 894,060 | 819,677 | 807,073 | 777,406 | 749,080 |
ROE | -20.80% | 5.96% | 11.32% | 16.85% | 25.34% | 34.26% | 41.66% | 39.98% | 42.55% | 42.24% | 44.26% | 37.28% | 28.17% | 21.15% | 17.85% | 14.33% | 8.62% | 11.01% | 11.10% | 12.39% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-146,979K ÷ $706,620K
= -20.80%
The Return on Equity (ROE) of AMN Healthcare Services Inc has shown significant volatility over the periods outlined in the data provided.
The ROE started at 12.39% in March 2020 before decreasing slightly to 11.10% in June 2020. It then remained relatively stable around the 11-12% range for the next few quarters, with a slight drop to 8.62% by December 2020.
From March 2021 onwards, there was a noticeable improvement in ROE, with successive increases in each quarter, reaching a peak of 44.26% in June 2022. This period indicated a strong performance in utilizing shareholder equity to generate profits.
However, from September 2022 onwards, there was a decline in ROE figures. The ROE dropped to 5.96% in September 2024 and turned negative at -20.80% by December 2024. This negative ROE suggests that the company's net income was insufficient to cover the equity in the business during that quarter, which may raise concerns about the company's financial health and profitability.
In conclusion, the company experienced fluctuations in its ROE over the period, with both positive and negative trends observed. Investors and stakeholders should closely monitor the company's financial performance to understand the factors influencing these changes in ROE and assess the company's ability to generate returns on shareholder equity sustainably.
Peer comparison
Dec 31, 2024